Neoleukin Therapeutics, Inc.
SEC Filing List
NLTX CIK: 0001404644
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 8-K | Current report filing | Neurogene Inc. | 04/20/2026 | ||
| 3 | Initial statement of beneficial ownershi... | Shafer Christina | Neurogene Inc. | 04/20/2026 | |
| DEF 14A | Definitive proxy statements | Neurogene Inc. | 04/16/2026 | ||
| DEFA14A | Definitive additional proxy soliciting m... | Neurogene Inc. | 04/16/2026 | ||
| ARS | Annual report to security holders | Neurogene Inc. | Broadridge Financial Solutions, Inc. /fa | 04/16/2026 | |
| 4 | Statement of changes in beneficial owner... | Jordan Julie | Neurogene Inc. | 03/30/2026 | |
| 4 | Statement of changes in beneficial owner... | Mcminn Rachel | Neurogene Inc. | 03/30/2026 | |
| 4 | Statement of changes in beneficial owner... | Cvijic Christine Mikail | Neurogene Inc. | 03/30/2026 | |
| 10-K | Annual report pursuant to Section 13 and... | Neurogene Inc. | 03/24/2026 | ||
| 8-K | Current report filing | Neurogene Inc. | 03/24/2026 | ||
| No record found. | |||||
| Load More | |||||
